Donation Programs
How is Treatment Access Supported in LMICs?
Donation Programs support access to medical products for patients in need where commercial accessibility is lacking, and funding for treatment is limited or unavailable, typically in low- and middle-income countries (LMICs). These programs are often implemented in collaboration with non-profit organizations, global health partners, and humanitarian stakeholders working to expand access to treatment.
Tanner Pharma designs and manages compliant, tailored Donation Programs that enable structured global access to unlicensed or high-cost treatments.
These programs are delivered in close partnership with Non-Governmental Organizations (NGOs), patient advocacy groups (PAGs), ministries of health, and international stakeholders. We support program sponsors with the GxP-compliant management of increasingly complex supply chain and quality assurance challenges to maintain product integrity, lengthy and bureaucratic regulatory processes, and a fluid and often volatile geopolitical environment.
Scenarios for Donation Programs
Donation Programs are often incubated and driven by the patient advocacy or product donation functions within companies but require cross-functional collaboration and support to ensure successful outcomes. Whether it’s a large company being measured by the Access to Medicine Index, or a smaller company with a socially-minded motivation to do more to support patients, Tanner Pharma has a lengthy track-record of supporting organizations with developing a tailored program that aligns to what a company is willing and able to support.
Core Services
Supply Chain & Logistics
Quality Assurance
Program Management
Regulatory Compliance
Regulatory Compliance
Program Management
Pharmacovigilance
Supply Chain & Logistics
Pharmacovigilance
Quality Assurance
How We Deliver Access Solutions
Explore real-world examples of how we navigate regulatory, geographic and supply complexities to deliver compliant, global access to essential therapies.